MedPath

BAQSIMI 3 MG POLVO NASAL EN ENVASE UNIDOSIS

BAQSIMI 3 MG POLVO NASAL EN ENVASE UNIDOSIS

Commercialized
Register Number

1191406001

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jan 17, 2020

Dosage Form

POLVO NASAL

Route: VÍA NASAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1191406001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

GLUCAGONActive
Quantity: 3 mg
Name: GLUCAGON

ATC CLASSIFICATION (3)

H04A
H04AA
H04AA01

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.